Sara A. Hurvitz, MD, FACP
Breast Cancer Chair
Senior Vice President and Director
Clinical Research Division, Fred Hutch
Professor
Clinical Research Division, Fred Hutch
Hurvitz started her pursuit of medicine in 1990 when she enrolled at the University of California, Irvine, and went on to earn dual degrees in biology and psychology. Hurvitz is a medical oncologist, clinical research leader, and senior vice president of the Clinical Research Division at Fred Hutch and head of the Division of Hematology and Oncology at the University of Washington Department of Medicine. Hurvitz specializes in the treatment of women with breast cancer. She is involved in constructing and implementing several national clinical trials testing new therapies while studying gene expression patterns in a variety of breast cancer populations to develop novel therapies.
Novel Agents in Early Trials for Breast Cancer
July 11th 2012CancerNetwork speaks with Dr. Sara Hurvitz, director of the breast cancer program at the University of California in Los Angeles. Dr. Hurvitz is actively involved in translational phase I/II breast cancer clinical trials as well as in research to better define distinct types of breast tumors to better design novel targeted therapies.
